Product information and disease description
Product description
97 evidence topics · 33 sources
Atebrioz (zilurgisertib)
Fibrodysplasia ossificans progressiva
- Manufacturer
- Mirum Pharmaceuticals
- Regulatory submission
- NDA submitted by May 2026
- Last updated